COCA-COLA EUROPACIFIC PARTNERS plc
No SEC Form 4 filings for $CCEP in the last 30 days.
See all $CCEP insider activity →UBS downgraded Coca-Cola Europacific Partners (LON: CCEP) to Neutral from Buy, cutting its price target to $107 from $109. Analyst Sanjeet Aujla cited stretched valuation after the stock rose 19% year-to-date and now trades about 20% above European staples peers. UBS said the downgrade is not tied to weaker operations and noted guidance could still be raised.
UBS downgraded Coca-Cola Europacific Partners to Neutral from Buy and cut its price target to $107 from $109, according to the note. The change affects investor expectations for the company’s valuation and outlook.
UBS downgraded Coca-Cola Europacific Partners (CCEP) to neutral from buy and cut its 12-month price target to $107 from $109, citing limited upside after a 19% YTD rally and a higher valuation. CCEP reported Q2 organic revenue growth of 3.3% and organic volume growth of 3.2% above consensus. Shares closed at $106.35 on Aug. 12.
Over the past 7 days, alphai's AI scored 5 news stories mentioning CCEP (COCA-COLA EUROPACIFIC PARTNERS plc). Coverage has been balanced: 1 bullish, 3 neutral, and 1 bearish.
Recent CCEP coverage spans earnings, market movers and financial news.
The downgrade is valuation-driven rather than operational, implying near-term upside may be capped unless fundamentals re-accelerate beyond what the market already prices.
The downgrade and lower PT can pressure near-term sentiment and relative performance versus peers, but it is not a fundamental disclosure.
The downgrade and target trim are a near-term sentiment headwind, but the article also notes CCEP reaffirmed 2026 guidance and beat on organic revenue/volume.
A broker downgrade to neutral is a near-term sentiment headwind, especially in a weak tape.
Routine buyback execution detail, likely modest support for sentiment and near-term float reduction, with limited incremental fundamental impact.
alphai scores every news story that mentions CCEP with an AI model for sentiment and relevance, and aggregates insider trades from COCA-COLA EUROPACIFIC PARTNERS plc's SEC EDGAR Form 4 filings. Figures refresh continuously.
UBS downgraded Coca-Cola Europacific Partners (LON: CCEP) to Neutral from Buy, cutting its price target to $107 from $109. Analyst Sanjeet Aujla cited stretched valuation after the stock rose 19% year-to-date and now trades about 20% above European staples peers. UBS said the downgrade is not tied to weaker operations and noted guidance could still be raised.
3 min readUBS downgraded Coca-Cola Europacific Partners to Neutral from Buy and cut its price target to $107 from $109, according to the note. The change affects investor expectations for the company’s valuation and outlook.
1 min readUBS downgraded Coca-Cola Europacific Partners (CCEP) to neutral from buy and cut its 12-month price target to $107 from $109, citing limited upside after a 19% YTD rally and a higher valuation. CCEP reported Q2 organic revenue growth of 3.3% and organic volume growth of 3.2% above consensus. Shares closed at $106.35 on Aug. 12.
4 min readFTSE 100 ended a quiet session down 39 points at 10,862.50. Vistry fell about 9% on reports its credit insurance cover was cut. Legal & General slid after Citi downgraded it to sell on valuation, trimming 2026-27 remittance forecasts. Brent rose to about $85 amid Strait of Hormuz deal headlines; US Fed cut odds fell after weak jobs data.
6 min readCoca-Cola Europacific Partners (CCEP) said it bought back shares from 3 to 7 Aug 2026 under its Feb 17, 2026 buyback program. It repurchased 210,000 ordinary shares on US trading venues and 84,868 on London venues, with prices ranging from USD 102.67 to 110.70 and GBP 76.40 to 82.25. Shares will be cancelled; up to EUR 1 billion expected.
3 min readCoca-Cola Europacific Partners (CCEP) reported Q2 2026 results on a half-year basis: revenue EUR 10.7B (+6.1%), operating profit EUR 1.5B (+8.1%), operating margin 13.8% (+30 bps), and diluted EPS EUR 2.20 (+10.6%). Free cash flow was EUR 435M in H1; management reaffirmed full-year FCF target of at least EUR 1.7B and completed EUR 600M of a EUR 1B buyback. Risks include Middle East commodity volatility.
4 min readCoca-Cola Europacific Partners (AMS:CCEP) reported half-year results, with revenues of €11b and statutory EPS of €4.26, both in line with analyst estimates, according to the article. For 2026, analysts forecast revenues of €21.6b and EPS of €4.37, unchanged from prior models. The consensus price target remains €95.14, with a range of €80.48 to €112.
6 min readCampari Group reported H1 2026 organic net sales of €1.5bn, down 1% year on year, with organic growth of +2.7%, and gross profit of €946m (+1.3%), citing innovation and changing consumer habits. Coca-Cola Europacific Partners (CCEP) said H1 revenue rose 6.1% and operating profit was 8.1%, supported by new variants and FIFA World Cup activations. A G Barr forecast H1 revenue of about £246m (+8%) despite an estimated £10m H1 revenue hit from distribution issues.
7 min readCoca-Cola Europacific Partners (CCEP) reported Q2 2026 results driven by volume growth and positive revenue per case, with Zero Sugar, Energy and Sports outperforming. Management cited FIFA World Cup activations, margin expansion of 30 bps, and reaffirmed full-year 2026 guidance despite 6 fewer trading days. Capex includes a Manila greenfield site in 2027 and cooler placements.
7 min readCoca-Cola Europacific Partners (CCEP) reported H1 2026 revenue of €10.7bn, up 4.4% reported and 6.1% FX neutral. Operating profit was €1.46bn reported (+6.9%) and profit after tax €991m (+5.8%). Total volume rose to 2,041m unit cases (+5.6%). Full-year guidance calls for ~3-4% revenue and ~7% operating profit growth.
4 min read
